Cargando…

Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients

QTc interval prolongation is a serious diabetic complication and increases mortality rate. Hyperglycemia inhibits the rapid component of delayed rectifier potassium channel currents (Ikr) and prolongs the QTc interval on electrocardiograms. Sevoflurane also inhibits the Ikr and causes QTc interval p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Seishi, Nakao, Shinichi, Kitaura, Atsuhiro, Iwamoto, Tatushige, Houri, Kei, Matsushima, Mayuka, Hamasaki, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711029/
https://www.ncbi.nlm.nih.gov/pubmed/29194447
http://dx.doi.org/10.1371/journal.pone.0188555
_version_ 1783282992513286144
author Kimura, Seishi
Nakao, Shinichi
Kitaura, Atsuhiro
Iwamoto, Tatushige
Houri, Kei
Matsushima, Mayuka
Hamasaki, Shinichi
author_facet Kimura, Seishi
Nakao, Shinichi
Kitaura, Atsuhiro
Iwamoto, Tatushige
Houri, Kei
Matsushima, Mayuka
Hamasaki, Shinichi
author_sort Kimura, Seishi
collection PubMed
description QTc interval prolongation is a serious diabetic complication and increases mortality rate. Hyperglycemia inhibits the rapid component of delayed rectifier potassium channel currents (Ikr) and prolongs the QTc interval on electrocardiograms. Sevoflurane also inhibits the Ikr and causes QTc interval prolongation. In fact, torsade de pointes occurred in a patient with poorly controlled diabetes mellitus during sevoflurane anesthesia. We enrolled 74 patients, including 37 normoglycemic patients (glycated hemoglobin [HbA1c]: <6.5%) (NG group) and 37 chronically hyperglycemic patients (HbA1c: ≥6.5%) (HG group). Anesthesia was induced with 2 mg/kg propofol and 0.3 μg/kg/min remifentanil, and maintained with 2% sevoflurane in 40% O(2) and 0.2–0.3 μg/kg/min remifentanil. The QT interval and Tp-e interval (from the peak to the end of the T wave) were measured before and at 5, 10, 30, 60, 90, and 120 min after the administration of sevoflurane and adjusted for the patient’s heart rate (QTc and Tp-ec, respectively). P-values of <0.05 were considered statistically significant. The QTc and the Tp-ec intervals of the two groups did not differ significantly before the administration of sevoflurane. The QTc interval gradually increased with time in both groups and was significantly longer than the baseline value at 10 min after the administration of sevoflurane in both groups. The QTc interval of the HG group was significantly longer than that of the NG group at 90 min and 120 min after the administration of sevoflurane. The Tp-ec interval was not affected by sevoflurane in either group.We have demonstrated that sevoflurane significantly prolongs the QTc interval, and that the extent of the prolongation is significantly greater in chronically hyperglycemic patients than in normoglycemic patients. Although Tp-ec is not affected by sevoflurane, it should be noted that the simultaneous blockade of potassium channels would increase the risk of arrhythmias.
format Online
Article
Text
id pubmed-5711029
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57110292017-12-15 Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients Kimura, Seishi Nakao, Shinichi Kitaura, Atsuhiro Iwamoto, Tatushige Houri, Kei Matsushima, Mayuka Hamasaki, Shinichi PLoS One Research Article QTc interval prolongation is a serious diabetic complication and increases mortality rate. Hyperglycemia inhibits the rapid component of delayed rectifier potassium channel currents (Ikr) and prolongs the QTc interval on electrocardiograms. Sevoflurane also inhibits the Ikr and causes QTc interval prolongation. In fact, torsade de pointes occurred in a patient with poorly controlled diabetes mellitus during sevoflurane anesthesia. We enrolled 74 patients, including 37 normoglycemic patients (glycated hemoglobin [HbA1c]: <6.5%) (NG group) and 37 chronically hyperglycemic patients (HbA1c: ≥6.5%) (HG group). Anesthesia was induced with 2 mg/kg propofol and 0.3 μg/kg/min remifentanil, and maintained with 2% sevoflurane in 40% O(2) and 0.2–0.3 μg/kg/min remifentanil. The QT interval and Tp-e interval (from the peak to the end of the T wave) were measured before and at 5, 10, 30, 60, 90, and 120 min after the administration of sevoflurane and adjusted for the patient’s heart rate (QTc and Tp-ec, respectively). P-values of <0.05 were considered statistically significant. The QTc and the Tp-ec intervals of the two groups did not differ significantly before the administration of sevoflurane. The QTc interval gradually increased with time in both groups and was significantly longer than the baseline value at 10 min after the administration of sevoflurane in both groups. The QTc interval of the HG group was significantly longer than that of the NG group at 90 min and 120 min after the administration of sevoflurane. The Tp-ec interval was not affected by sevoflurane in either group.We have demonstrated that sevoflurane significantly prolongs the QTc interval, and that the extent of the prolongation is significantly greater in chronically hyperglycemic patients than in normoglycemic patients. Although Tp-ec is not affected by sevoflurane, it should be noted that the simultaneous blockade of potassium channels would increase the risk of arrhythmias. Public Library of Science 2017-12-01 /pmc/articles/PMC5711029/ /pubmed/29194447 http://dx.doi.org/10.1371/journal.pone.0188555 Text en © 2017 Kimura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kimura, Seishi
Nakao, Shinichi
Kitaura, Atsuhiro
Iwamoto, Tatushige
Houri, Kei
Matsushima, Mayuka
Hamasaki, Shinichi
Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title_full Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title_fullStr Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title_full_unstemmed Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title_short Sevoflurane causes greater QTc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
title_sort sevoflurane causes greater qtc interval prolongation in chronically hyperglycemic patients than in normoglycemic patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711029/
https://www.ncbi.nlm.nih.gov/pubmed/29194447
http://dx.doi.org/10.1371/journal.pone.0188555
work_keys_str_mv AT kimuraseishi sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT nakaoshinichi sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT kitauraatsuhiro sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT iwamototatushige sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT hourikei sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT matsushimamayuka sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients
AT hamasakishinichi sevofluranecausesgreaterqtcintervalprolongationinchronicallyhyperglycemicpatientsthaninnormoglycemicpatients